Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)
Due: March 5, 2026 The goal of this Notice of Funding Opportunity (NOFO) is to accelerate the establishment of effective and reliable biomarkers of Alzheimers disease (AD) and AD-related dementias (ADRD) for usein therapy/medical product Read More